269 related articles for article (PubMed ID: 17440943)
1. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.
Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Hollis BW; Giovannucci E
Prostate; 2007 Jun; 67(9):911-23. PubMed ID: 17440943
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
3. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
Köstner K; Denzer N; Müller CS; Klein R; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3511-36. PubMed ID: 19667145
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Receptor Polymorphisms and Cancer.
Gnagnarella P; Raimondi S; Aristarco V; Johansson HA; Bellerba F; Corso F; Gandini S
Adv Exp Med Biol; 2020; 1268():53-114. PubMed ID: 32918214
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor polymorphisms and cancer.
Gandini S; Gnagnarella P; Serrano D; Pasquali E; Raimondi S
Adv Exp Med Biol; 2014; 810():69-105. PubMed ID: 25207361
[TBL] [Abstract][Full Text] [Related]
6. [The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes].
Wysoczańska-Klaczyńska A; Ślęzak A; Hetman M; Barg E
Pediatr Endocrinol Diabetes Metab; 2018; 24(2):96-105. PubMed ID: 30300431
[TBL] [Abstract][Full Text] [Related]
7. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women.
Dasgupta S; Dutta J; Annamaneni S; Kudugunti N; Battini MR
Indian J Med Res; 2015 Sep; 142(3):276-85. PubMed ID: 26458343
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.
Tworoger SS; Gates MA; Lee IM; Buring JE; Titus-Ernstoff L; Cramer D; Hankinson SE
Cancer Res; 2009 Mar; 69(5):1885-91. PubMed ID: 19223536
[TBL] [Abstract][Full Text] [Related]
9. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.
Abbas S; Nieters A; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Breast Cancer Res; 2008; 10(2):R31. PubMed ID: 18419802
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.
Iqbal Mu; Khan TA; Maqbool SA
PLoS One; 2015; 10(3):e0122657. PubMed ID: 25799416
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
13. Mycosis Fungoides and Vitamin D Status: Analyses of Serum 25-Hydroxyvitamin D Levels and Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene.
Incel Uysal P; Alli N; Hayran Y; Candar T
Acta Dermatovenerol Croat; 2018 Apr; 26(1):8-14. PubMed ID: 29782293
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
Cicek MS; Liu X; Schumacher FR; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2549-52. PubMed ID: 17164384
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.
Penna-Martinez M; Ramos-Lopez E; Stern J; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Wahl RA; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
Thyroid; 2009 Jun; 19(6):623-8. PubMed ID: 19499989
[TBL] [Abstract][Full Text] [Related]
17. Associations between polymorphisms in the vitamin D receptor and breast cancer risk.
Chen WY; Bertone-Johnson ER; Hunter DJ; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2335-9. PubMed ID: 16214913
[TBL] [Abstract][Full Text] [Related]
18. The possible role of maternal and placental
Farajian-Mashhadi F; Eskandari F; Rezaei M; Eskandari F; Najafi D; Teimoori B; Moradi-Sharbabak M; Salimi S
Clin Exp Hypertens; 2020; 42(2):171-176. PubMed ID: 31006279
[No Abstract] [Full Text] [Related]
19. Vitamin D receptor and Alzheimer's disease: a genetic and functional study.
Wang L; Hara K; Van Baaren JM; Price JC; Beecham GW; Gallins PJ; Whitehead PL; Wang G; Lu C; Slifer MA; Züchner S; Martin ER; Mash D; Haines JL; Pericak-Vance MA; Gilbert JR
Neurobiol Aging; 2012 Aug; 33(8):1844.e1-9. PubMed ID: 22306846
[TBL] [Abstract][Full Text] [Related]
20. The Association Between
Duan GQ; Zheng X; Li WK; Zhang W; Li Z; Tan W
Genet Test Mol Biomarkers; 2020 May; 24(5):285-295. PubMed ID: 32255717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
